RxDoctor Payments Data

Wendy Huang, MD

Ophthalmology · Glendale, AZNPI 1952564114

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,750 of the $72,774 with a category attached, or 93.1%. Baxter Healthcare accounts for 93.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $34,883 and has fallen 97.2% since, to $979 in 2025. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,774in general payments, 2019–2025

Across 54 payments — averaging $1347.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$68K
  • Microsurgical Technology, Inc.$3K
  • Bausch & Lomb Americas Inc.$522
  • Glaukos Corporation$487
  • Biotissue Holdings Inc.$244
  • Ocular Therapeutix, Inc.$174
  • plus $820 from 11 others

What the payments were for

  • Consulting fees$67,75093%
  • Food & beverage$2,2473%
  • Charitable contribution$2,7784%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,774 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.

See all ophthalmology providers in Arizona

Medicare billing

Part B allowed, 2024
$67,924
Medicare patients
150
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate29$1,184
MoxifloxacinMoxifloxacin Hcl23$712
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha24$289
Diclofenac Sodium17$197
ErythromycinErythromycin Base16$157
Latanoprost12$101

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →